Healthcare

  Hormone replacement therapy market accounted for US$ 7.16 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 7.50%. Hormone replacement therapy (HRT), also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause.These symptoms can include hot flashes, vaginal atrophy, accelerated skin aging, vaginal dryness, decreased muscle mass, sexual dysfunction, and bone loss. They are in large part related to the diminished levels of sex hormones that occur during menopause. The main hormonal medications used in HRT for menopausal symptoms are estrogens and progestogens, among which progesterone is the major naturally-occurring female sex hormone and also a manufactured medication used in menopausal hormone therapy. Though both can have symptomatic benefits, progestogen is specifically added to estrogen regimens when the uterus is st...

The report  " Global Erythropoietin Drugs Market, by Drug Class (Biologics and Biosimilar),   by Product ( Epoetin-Alfa ,  Epoetin-Beta ,  Darbepoetin-Alfa, and Others (Pegylated Erythropoietin and Carbamylated Erythropo ietin)), by Application ( Cancer ,  Hematology ,  Renal diseases , and  Neur ology), and Region - Global Forecast to 2029"  Erythropoietin Drugs Market  accounted for US$ 11 billion in 2020 and is estimated to be US$ 25.9 billion by 2030 and is anticipated to register a CAGR of 8.9%. This is attributed to increasing prevalence of anemia, caner, chronic kidney disease, bone marrow dysfunction, and HIV, coupled with rising incidences of deficiency of iron, vitamin B12, and folic acid due to desk-bound lifestyle. Key Highlights : On May 2018, Pfizer Inc. announced that United States Food and Drug Administration (USFDA) approved “RETACRIT” (epoetin alfa-epbx)  a biosimilar to Epogen and Procrit (epoetin a...

  Gene Therapy Market   accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with a working copy of the gene. Genes are the composition of an acid which is consists of essential information which is used in the protein production that is necessary for best possible functioning of body. This acid is deoxyribonucleic acid. When proteins are made imperfectly then it is termed as gene mutations, which results into the genetic disorder Gene therapy is projected to introduce healthy gene within the damaged cells that are used to counteract for various abnormal genes. They are also intended to make proteins of interest. The report  "   Global Gene Th...

  The report  " Global  Magnetic Resonance Imaging (MRI) Market , By Product Type (Less than 0.5T MRI, 5T MRI, and 3T MRI), By Application Type (Orthopedic, Spine, Neurology, Cardiovascular, Head and Neck, Abdominal and Prostate, and Others (Breast, Vascular, Muscles, and Brain)), By Strength Type (Low-Field MRI, Mid-Field MRI, and High-Field MRI), By End Users (Hospitals, Ambulatory Surgical Centers, and Diagnostic Imaging Centers), and  By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030 .  Rapidly increasing ageing population is a major factor projected to drive the growth of global magnetic resonance imaging (MRI) systems market throughout the forecast period. Further, continuous innovation by producers in magnetic resonance imaging system that provides image precision, accuracy is other factor anticipated to propel the target market growth over the forecast period. ...

  Clinical Trials Market accounted for US$ 42.4 billion in 2020 and is estimated to be US$ 74.2 billion by 2030 and is anticipated to register a CAGR of 5.5% Clinical trials are tests that are carried out under the auspices of clinical research and adhere to a strict methodology. Clinical trials are used to assess the efficacy and safety of pharmaceuticals or medical devices by observing how they affect large groups of people. Government health institutions, such as the National Institutes of Health (NIH), researchers linked with a hospital or university medical school, independent researchers, or private enterprise undertake clinical research trials. These tests are generally used to gather information about the safety and efficacy of newly produced pharmaceuticals. The results of the clinical trials are required for drug approval and market introduction. Clinical trials are divided into three phases (I, II, and III), depending on a variety of circumstances. The report "Glo...